ARTICLE | Clinical News
Buprenorphine hemiadipate: Phase I data
May 16, 2016 7:00 AM UTC
Indivior said the open-label, U.K. Phase I RB-EU-14-0001 trial in healthy volunteers showed that oral RBP-6300 did not achieve “the anticipated PK profile in humans to justify proceeding further with ...